JUBILANT PHARMOVA LIMITED (JUBLPHARMA)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 1,678.00 1,586.90 1,680.30 1,677.10 175.86 1,731.70 1,752.30 1,821.70 1,928.80 1,900.70 1,966.40 2,122.50
YOY Revenue Growth % 28.04% 4.78% 5.05% 8.03% -89.52% 9.12% 4.28% 8.62% 996.78% 9.76% 12.22% 16.51%
Other Income 4.45 8.60 9.90 35.80 1.44 14.00 21.70 9.20 11.90 12.00 9.80 20.50
Total Income 1,682.45 1,595.50 1,690.20 1,712.90 177.30 1,745.70 1,774.00 1,830.90 1,940.70 1,912.70 1,976.20 2,143.00
Total Expenses + 1,371.36 1,325.30 1,345.60 1,354.70 145.71 1,383.80 1,377.10 1,426.90 1,731.30 1,758.20 1,780.00 2,009.80
Cost of Materials Consumed 442.35 428.10 464.40 431.50 49.73 465.30 469.00 467.00 584.00 520.50 564.90 592.10
Employee Benefit Expense 534.30 547.70 531.80 581.50 55.50 552.90 564.30 560.10 590.60 591.10 636.20 706.40
Other Expenses 394.71 349.50 349.40 341.70 40.48 365.60 343.80 399.80 366.70 401.80 392.30 410.30
Operating Profit 306.64 261.60 334.70 322.40 30.15 347.90 375.20 394.80 197.50 142.50 186.40 112.70
OPM % 18.3% 16.5% 19.9% 19.2% 17.1% 20.1% 21.4% 21.7% 10.2% 7.5% 9.5% 5.3%
Profit Before Tax + -103.12 26.60 89.00 87.90 -5.71 499.70 144.50 130.80 206.10 154.50 190.40 93.50
Tax Expense -2.61 20.60 26.90 21.50 0.47 17.90 42.00 30.10 54.80 52.00 70.50 37.70
Tax % - 77.4% 30.2% 24.5% - 3.6% 29.1% 23% 26.6% 33.7% 37% 40.3%
Profit After Tax -100.51 6.00 62.10 66.40 -6.18 481.80 102.50 100.70 151.30 102.50 119.90 55.80
EPS (Basic) -6.15 0.40 3.94 4.22 -3.69 30.44 6.47 6.37 9.71 6.49 7.59 3.52

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 7,234.50 670.29 6,281.73 6,059.17
YOY Revenue Growth % 979.31% -89.33% 3.67% -
Other Income 56.80 6.87 38.33 82.28
Total Income 7,291.30 677.16 6,320.06 6,141.45
Total Expenses + 6,669.70 548.27 5,293.96 4,834.53
Cost of Materials Consumed 1,985.30 182.13 1,666.41 1,348.70
Employee Benefit Expense 2,267.90 221.60 2,166.02 2,043.39
Other Expenses 1,475.90 144.54 1,461.53 1,442.44
Operating Profit 564.80 122.02 987.77 1,224.64
OPM % 7.8% 18.2% 15.7% 20.2%
Profit Before Exceptional 621.60 31.53 72.35 640.43
Exceptional Items 359.50 -16.89 -56.82 0.00
Profit Before Tax + 981.10 14.64 15.53 640.43
Tax Expense 144.80 7.37 80.41 227.41
Tax % 14.8% 50.3% 517.8% 35.5%
Profit After Tax 836.30 7.27 -64.88 413.02
EPS (Basic) 52.99 4.87 -3.83 26.00

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 9,179.20 767.24 7,394.25 0.00
Property, Plant & Equipment 2,132.30 215.78 2,297.53 0.00
Capital Work in Progress 2,714.70 125.23 773.25 0.00
Non-Current Investments 36.00 3.44 32.79 0.00
Goodwill 2,541.00 246.39 2,428.59 0.00
Other Intangible Assets 181.40 19.25 457.14 0.00
Current Assets + 3,509.70 363.22 3,762.40 0.00
Inventories 1,129.20 128.96 1,380.53 0.00
Trade Receivables 891.50 91.59 961.24 0.00
Cash and Cash Equivalents 1,088.30 95.64 1,013.92 0.00
Current Investments 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00
Equity Share Capital 15.80 1.58 15.91 0.00
Other Equity 6,239.10 541.81 5,383.37 0.00
Non-Current Liabilities 4,353.20 423.84 3,992.46 0.00
Current Liabilities 2,164.60 188.90 1,772.40 0.00
Total Liabilities 6,517.80 612.74 5,764.86 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 1,072.10 97.13 660.67 837.54
Cash from Investing Activities 487.70 -60.79 -544.41 -380.37
Cash from Financing Activities -1,452.70 -43.25 -156.69 -32.60
Net Increase/Decrease in Cash 131.90 -5.75 30.10 481.86